AU3028589A - Use of quinolizine and quinolizinone derivatives in the manufacture of medicaments for the treatment of cardiac arrhythmia - Google Patents

Use of quinolizine and quinolizinone derivatives in the manufacture of medicaments for the treatment of cardiac arrhythmia

Info

Publication number
AU3028589A
AU3028589A AU30285/89A AU3028589A AU3028589A AU 3028589 A AU3028589 A AU 3028589A AU 30285/89 A AU30285/89 A AU 30285/89A AU 3028589 A AU3028589 A AU 3028589A AU 3028589 A AU3028589 A AU 3028589A
Authority
AU
Australia
Prior art keywords
quinolizine
medicaments
manufacture
treatment
cardiac arrhythmia
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU30285/89A
Other languages
English (en)
Inventor
Not Given Name
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharmaceuticals Inc
Original Assignee
Merrell Dow Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharmaceuticals Inc filed Critical Merrell Dow Pharmaceuticals Inc
Publication of AU3028589A publication Critical patent/AU3028589A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/18—Bridged systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
AU30285/89A 1988-03-01 1989-02-23 Use of quinolizine and quinolizinone derivatives in the manufacture of medicaments for the treatment of cardiac arrhythmia Abandoned AU3028589A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP88400482A EP0330788A1 (en) 1988-03-01 1988-03-01 Use of quinolizine and quinolizinone derivatives in the manufacture of medicaments for the treatment of cardiac arrhythmia
EP88400482 1988-03-01

Publications (1)

Publication Number Publication Date
AU3028589A true AU3028589A (en) 1989-09-07

Family

ID=8200359

Family Applications (1)

Application Number Title Priority Date Filing Date
AU30285/89A Abandoned AU3028589A (en) 1988-03-01 1989-02-23 Use of quinolizine and quinolizinone derivatives in the manufacture of medicaments for the treatment of cardiac arrhythmia

Country Status (6)

Country Link
EP (2) EP0330788A1 (da)
JP (1) JPH01268634A (da)
KR (1) KR890014112A (da)
AU (1) AU3028589A (da)
DK (1) DK95489A (da)
ZA (1) ZA891366B (da)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU624115B2 (en) * 1988-02-23 1992-06-04 Aventis Inc. Use of quinolizine and quinolizinone derivatives in the manufacture of medicaments
AU652009B2 (en) * 1990-12-21 1994-08-11 Aventisub Ii Inc. Use of certain esters of hexahydro-8-hydroxy-2,6-methano- 2H-quinolizin-3(4H)-one and related compounds for treating cognitive disorders

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4992446A (en) * 1989-09-05 1991-02-12 G. D. Searle & Co. Tricyclic quinolizine amides
EP0517984A1 (en) * 1991-06-11 1992-12-16 Merrell Dow Pharmaceuticals Inc. Derivatives of amide analogs of certain methano bridged quinolizines
US5955470A (en) * 1991-06-11 1999-09-21 Merrell Pharmaceuticals, Inc. Derivatives of amide analogs of certain methano bridged quinolizines
WO2007072507A2 (en) * 2005-12-23 2007-06-28 Usv Limited Polymorphic forms of dolasetron base and processes of preparing dolasetron base, its polymorphic forms and salt thereof
US20070203175A1 (en) 2006-01-05 2007-08-30 Janos Hajko Productioin of dolasetron
AR073497A1 (es) 2008-09-05 2010-11-10 Elan Pharm Inc Compuestos de pirazolilo policiclicos de n-sulfonamido
WO2011102388A1 (ja) * 2010-02-16 2011-08-25 株式会社エーピーアイ コーポレーション １－アミノ－１－アルコキシカルボニル－２－ビニルシクロプロパンの製造方法
CN102180878B (zh) * 2010-07-02 2013-06-26 成都新恒创药业有限公司 一种多拉司琼异构体或其盐及其制备方法和其应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0220011A3 (en) * 1985-10-12 1990-01-03 Beecham Group Plc Use of azabicloalkylbenzamides in the treatment of gastrointestinal motility disorders, migraine, emesis, cluster headaches, trigeminal neuralgia and arrhythmia
ZA878096B (en) * 1986-11-03 1988-04-26 Merrell Dow Pharmaceuticals Inc. Esters of hexahydro-8-hydroxy-2,6-methano-2h-quinolizin-3(4h)-one and related compounds

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU624115B2 (en) * 1988-02-23 1992-06-04 Aventis Inc. Use of quinolizine and quinolizinone derivatives in the manufacture of medicaments
AU652009B2 (en) * 1990-12-21 1994-08-11 Aventisub Ii Inc. Use of certain esters of hexahydro-8-hydroxy-2,6-methano- 2H-quinolizin-3(4H)-one and related compounds for treating cognitive disorders

Also Published As

Publication number Publication date
ZA891366B (en) 1989-11-29
KR890014112A (ko) 1989-10-21
EP0330824A1 (en) 1989-09-06
JPH01268634A (ja) 1989-10-26
DK95489A (da) 1989-09-02
DK95489D0 (da) 1989-02-28
EP0330788A1 (en) 1989-09-06

Similar Documents

Publication Publication Date Title
IL88182A0 (en) Derivatives of 1-desoxynojirimicyin and 1-desoxymannonojirimycin,their preparation and their use in medicaments
AU649605B2 (en) Retinal, derivatives and their therapeutic use
AU589371B2 (en) Purine derivatives and use as therapeutic agent
AU4467589A (en) Treatment of skin diseases with artemisinin and derivatives
EP0280301A3 (en) Biocompatible ventricular assist and arrhythmia control device
AU609390B2 (en) Cyclodextrinclathrates of carbacycline derivatives and their use as medicinal drugs
AU4658489A (en) Use of acetyl d-carnitine in the therapeutic treatment of glaucoma
AU3072989A (en) Skin treatment composition
EP0278173A3 (en) Use of heterocyclic derivatives in the treatment of depressions
KR950005743B1 (en) Thiazole derivatives, their preparation and their use in the treatment of diabetes complications
AU8487191A (en) 2-aminopyrimidine-4-caroxamide derivatives, their preparation and their use in therapy
AU1907788A (en) N-aminobutyl-n-phenylarylamide derivatives, their preparation and their application in therapy
AU3028589A (en) Use of quinolizine and quinolizinone derivatives in the manufacture of medicaments for the treatment of cardiac arrhythmia
GR3003145T3 (en) Imidazopyridine derivatives, their preparation and therapeutical use
ZA864610B (en) Use of benzamido-azabicyclo compounds in the treatment of migraine,nausea,vomiting and cardiac arrhythmia
AU5201793A (en) Alpha, omega-diarylalkane derivatives, their preparation and their use in the treatment and prevention of circulatory diseases and psychosis
EP0370115A4 (en) Catheter for diagnosis and therapy
AU2135988A (en) Benzopyridazinone and pyridopyridazinone compounds and their use in the treatment of congestive heart failure
IL88608A0 (en) 3-hydroxy-2-(4-methoxyphenyl)-5-(2-methylaminoethyl)-2-3,dihydro-5h-1,5-benzothiazepin-4-one derivatives,their preparation and their application in therapy
IL91451A0 (en) Pharmaceutical compositions comprising azapiron compounds and their use in the treatment of addiction
EP0294538A3 (en) Use of nigericin in the treatment of viral diseases
AU3434489A (en) Skin treatment formulations
AU1450788A (en) Thiophene-2-carbox-amide derivatives and their pharmaceutical use
AU3315289A (en) Benzothiazepin-4-one derivatives, their preparation and their application in therapy
AU4096789A (en) The use of lactam derivatives in the treatment of cognitive disorders